Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 114 | Code: MBI-1635436

Migraine Headache Drugs Market by Products (Almotriptan, Eletriptan, Sumatriptan, Rizatriptan), by Applications (Acute Migraine, Common Migraine, Classic Migraine, Chronic Migraine) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Migraine Headache Drugs Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Migraine Headache Drugs Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Migraine Headache Drugs Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Pfizer
  • Novartis
  • Johnson & Johnson
  • GSK
  • Merck
  • Eli Lilly
  • Teva
  • AstraZeneca
  • Sun Pharma
  • Grunenthal
  • Endo Pharmaceuticals
  • Mylan
  • Bayer
  • Amneal Pharmaceuticals
  • Apotex
  • Ajanta Pharma
  • Allergan

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Migraine Headache Drugs Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Almotriptan
  • Eletriptan
  • Sumatriptan
  • Rizatriptan
  • Zolmitriptan
  • Naratriptan
  • Frovatriptan
  • Others

By Application

  • Acute Migraine
  • Common Migraine
  • Classic Migraine
  • Chronic Migraine
  • Other Migraines

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Migraine Headache Drugs Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Migraine Headache Drugs Market?

Regional Insights:

The government initiative increasing the development activities of the Migraine Headache Drugs Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Migraine Headache Drugs Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Almotriptan
        1.2.3 Eletriptan
        1.2.4 Sumatriptan
        1.2.5 Rizatriptan
        1.2.6 Zolmitriptan
        1.2.7 Naratriptan
        1.2.8 Frovatriptan
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Migraine Headache Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Acute Migraine
        1.3.3 Common Migraine
        1.3.4 Classic Migraine
        1.3.5 Chronic Migraine
        1.3.6 Other Migraines
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Migraine Headache Drugs Market Perspective (2017-2028)
    2.2 Migraine Headache Drugs Growth Trends by Region
        2.2.1 Migraine Headache Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Migraine Headache Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Migraine Headache Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Migraine Headache Drugs Market Dynamics
        2.3.1 Migraine Headache Drugs Industry Trends
        2.3.2 Migraine Headache Drugs Market Drivers
        2.3.3 Migraine Headache Drugs Market Challenges
        2.3.4 Migraine Headache Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Migraine Headache Drugs Players by Revenue
        3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2017-2022)
        3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue
    3.4 Global Migraine Headache Drugs Market Concentration Ratio
        3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2021
    3.5 Migraine Headache Drugs Key Players Head office and Area Served
    3.6 Key Players Migraine Headache Drugs Product Solution and Service
    3.7 Date of Enter into Migraine Headache Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Headache Drugs Breakdown Data by Type
    4.1 Global Migraine Headache Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2023-2028)
5 Migraine Headache Drugs Breakdown Data by Application
    5.1 Global Migraine Headache Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Migraine Headache Drugs Market Size (2017-2028)
    6.2 North America Migraine Headache Drugs Market Size by Type
        6.2.1 North America Migraine Headache Drugs Market Size by Type (2017-2022)
        6.2.2 North America Migraine Headache Drugs Market Size by Type (2023-2028)
        6.2.3 North America Migraine Headache Drugs Market Share by Type (2017-2028)
    6.3 North America Migraine Headache Drugs Market Size by Application
        6.3.1 North America Migraine Headache Drugs Market Size by Application (2017-2022)
        6.3.2 North America Migraine Headache Drugs Market Size by Application (2023-2028)
        6.3.3 North America Migraine Headache Drugs Market Share by Application (2017-2028)
    6.4 North America Migraine Headache Drugs Market Size by Country
        6.4.1 North America Migraine Headache Drugs Market Size by Country (2017-2022)
        6.4.2 North America Migraine Headache Drugs Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Migraine Headache Drugs Market Size (2017-2028)
    7.2 Europe Migraine Headache Drugs Market Size by Type
        7.2.1 Europe Migraine Headache Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Migraine Headache Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Migraine Headache Drugs Market Share by Type (2017-2028)
    7.3 Europe Migraine Headache Drugs Market Size by Application
        7.3.1 Europe Migraine Headache Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Migraine Headache Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Migraine Headache Drugs Market Share by Application (2017-2028)
    7.4 Europe Migraine Headache Drugs Market Size by Country
        7.4.1 Europe Migraine Headache Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Migraine Headache Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Migraine Headache Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Migraine Headache Drugs Market Size by Type
        8.2.1 Asia-Pacific Migraine Headache Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Migraine Headache Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Migraine Headache Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Migraine Headache Drugs Market Size by Application
        8.3.1 Asia-Pacific Migraine Headache Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Migraine Headache Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Migraine Headache Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region
        8.4.1 Asia-Pacific Migraine Headache Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Migraine Headache Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Migraine Headache Drugs Market Size (2017-2028)
    9.2 Latin America Migraine Headache Drugs Market Size by Type
        9.2.1 Latin America Migraine Headache Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Migraine Headache Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Migraine Headache Drugs Market Share by Type (2017-2028)
    9.3 Latin America Migraine Headache Drugs Market Size by Application
        9.3.1 Latin America Migraine Headache Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Migraine Headache Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Migraine Headache Drugs Market Share by Application (2017-2028)
    9.4 Latin America Migraine Headache Drugs Market Size by Country
        9.4.1 Latin America Migraine Headache Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Migraine Headache Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Migraine Headache Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Migraine Headache Drugs Market Size by Type
        10.2.1 Middle East & Africa Migraine Headache Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Migraine Headache Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Migraine Headache Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Migraine Headache Drugs Market Size by Application
        10.3.1 Middle East & Africa Migraine Headache Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Migraine Headache Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Migraine Headache Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country
        10.4.1 Middle East & Africa Migraine Headache Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Migraine Headache Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Migraine Headache Drugs Introduction
        11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Migraine Headache Drugs Introduction
        11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 GSK
        11.4.1 GSK Company Details
        11.4.2 GSK Business Overview
        11.4.3 GSK Migraine Headache Drugs Introduction
        11.4.4 GSK Revenue in Migraine Headache Drugs Business (2017-2022)
        11.4.5 GSK Recent Developments
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Migraine Headache Drugs Introduction
        11.5.4 Merck Revenue in Migraine Headache Drugs Business (2017-2022)
        11.5.5 Merck Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Migraine Headache Drugs Introduction
        11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2017-2022)
        11.6.5 Eli Lilly Recent Developments
    11.7 Teva
        11.7.1 Teva Company Details
        11.7.2 Teva Business Overview
        11.7.3 Teva Migraine Headache Drugs Introduction
        11.7.4 Teva Revenue in Migraine Headache Drugs Business (2017-2022)
        11.7.5 Teva Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Migraine Headache Drugs Introduction
        11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2017-2022)
        11.8.5 AstraZeneca Recent Developments
    11.9 Sun Pharma
        11.9.1 Sun Pharma Company Details
        11.9.2 Sun Pharma Business Overview
        11.9.3 Sun Pharma Migraine Headache Drugs Introduction
        11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2017-2022)
        11.9.5 Sun Pharma Recent Developments
    11.10 Grunenthal
        11.10.1 Grunenthal Company Details
        11.10.2 Grunenthal Business Overview
        11.10.3 Grunenthal Migraine Headache Drugs Introduction
        11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2017-2022)
        11.10.5 Grunenthal Recent Developments
    11.11 Endo Pharmaceuticals
        11.11.1 Endo Pharmaceuticals Company Details
        11.11.2 Endo Pharmaceuticals Business Overview
        11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction
        11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022)
        11.11.5 Endo Pharmaceuticals Recent Developments
    11.12 Mylan
        11.12.1 Mylan Company Details
        11.12.2 Mylan Business Overview
        11.12.3 Mylan Migraine Headache Drugs Introduction
        11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2017-2022)
        11.12.5 Mylan Recent Developments
    11.13 Bayer
        11.13.1 Bayer Company Details
        11.13.2 Bayer Business Overview
        11.13.3 Bayer Migraine Headache Drugs Introduction
        11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2017-2022)
        11.13.5 Bayer Recent Developments
    11.14 Amneal Pharmaceuticals
        11.14.1 Amneal Pharmaceuticals Company Details
        11.14.2 Amneal Pharmaceuticals Business Overview
        11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction
        11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022)
        11.14.5 Amneal Pharmaceuticals Recent Developments
    11.15 Apotex
        11.15.1 Apotex Company Details
        11.15.2 Apotex Business Overview
        11.15.3 Apotex Migraine Headache Drugs Introduction
        11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2017-2022)
        11.15.5 Apotex Recent Developments
    11.16 Ajanta Pharma
        11.16.1 Ajanta Pharma Company Details
        11.16.2 Ajanta Pharma Business Overview
        11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction
        11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2017-2022)
        11.16.5 Ajanta Pharma Recent Developments
    11.17 Allergan
        11.17.1 Allergan Company Details
        11.17.2 Allergan Business Overview
        11.17.3 Allergan Migraine Headache Drugs Introduction
        11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2017-2022)
        11.17.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Almotriptan Table 3. Key Players of Eletriptan Table 4. Key Players of Sumatriptan Table 5. Key Players of Rizatriptan Table 6. Key Players of Zolmitriptan Table 7. Key Players of Naratriptan Table 8. Key Players of Frovatriptan Table 9. Key Players of Others Table 10. Global Migraine Headache Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 11. Global Migraine Headache Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 12. Global Migraine Headache Drugs Market Size by Region (2017-2022) & (US$ Million) Table 13. Global Migraine Headache Drugs Market Share by Region (2017-2022) Table 14. Global Migraine Headache Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 15. Global Migraine Headache Drugs Market Share by Region (2023-2028) Table 16. Migraine Headache Drugs Market Trends Table 17. Migraine Headache Drugs Market Drivers Table 18. Migraine Headache Drugs Market Challenges Table 19. Migraine Headache Drugs Market Restraints Table 20. Global Migraine Headache Drugs Revenue by Players (2017-2022) & (US$ Million) Table 21. Global Migraine Headache Drugs Revenue Share by Players (2017-2022) Table 22. Global Top Migraine Headache Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2021) Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2021 Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2017-2022) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Migraine Headache Drugs Product Solution and Service Table 27. Date of Enter into Migraine Headache Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million) Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2017-2022) Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2023-2028) Table 33. Global Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million) Table 34. Global Migraine Headache Drugs Revenue Share by Application (2017-2022) Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 36. Global Migraine Headache Drugs Revenue Share by Application (2023-2028) Table 37. North America Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million) Table 38. North America Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million) Table 39. North America Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million) Table 40. North America Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million) Table 41. North America Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million) Table 42. North America Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million) Table 43. Europe Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million) Table 44. Europe Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million) Table 45. Europe Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million) Table 46. Europe Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million) Table 47. Europe Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million) Table 48. Europe Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million) Table 49. Asia Pacific Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million) Table 50. Asia Pacific Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million) Table 51. Asia Pacific Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million) Table 52. Asia Pacific Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million) Table 53. Asia Pacific Migraine Headache Drugs Market Size by Region (2017-2022) & (US$ Million) Table 54. Asia Pacific Migraine Headache Drugs Market Size by Region (2023-2028) & (US$ Million) Table 55. Latin America Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million) Table 56. Latin America Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million) Table 57. Latin America Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million) Table 58. Latin America Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million) Table 59. Latin America Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million) Table 60. Latin America Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million) Table 61. Middle East and Africa Migraine Headache Drugs Market Size by Type (2017-2022) & (US$ Million) Table 62. Middle East and Africa Migraine Headache Drugs Market Size by Type (2023-2028) & (US$ Million) Table 63. Middle East and Africa Migraine Headache Drugs Market Size by Application (2017-2022) & (US$ Million) Table 64. Middle East and Africa Migraine Headache Drugs Market Size by Application (2023-2028) & (US$ Million) Table 65. Middle East and Africa Migraine Headache Drugs Market Size by Country (2017-2022) & (US$ Million) Table 66. Middle East and Africa Migraine Headache Drugs Market Size by Country (2023-2028) & (US$ Million) Table 67. Pfizer Company Details Table 68. Pfizer Business Overview Table 69. Pfizer Migraine Headache Drugs Product Table 70. Pfizer Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 71. Pfizer Recent Developments Table 72. Novartis Company Details Table 73. Novartis Business Overview Table 74. Novartis Migraine Headache Drugs Product Table 75. Novartis Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 76. Novartis Recent Developments Table 77. Johnson & Johnson Company Details Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Migraine Headache Drugs Product Table 80. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 81. Johnson & Johnson Recent Developments Table 82. GSK Company Details Table 83. GSK Business Overview Table 84. GSK Migraine Headache Drugs Product Table 85. GSK Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 86. GSK Recent Developments Table 87. Merck Company Details Table 88. Merck Business Overview Table 89. Merck Migraine Headache Drugs Product Table 90. Merck Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 91. Merck Recent Developments Table 92. Eli Lilly Company Details Table 93. Eli Lilly Business Overview Table 94. Eli Lilly Migraine Headache Drugs Product Table 95. Eli Lilly Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 96. Eli Lilly Recent Developments Table 97. Teva Company Details Table 98. Teva Business Overview Table 99. Teva Migraine Headache Drugs Product Table 100. Teva Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 101. Teva Recent Developments Table 102. AstraZeneca Company Details Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Migraine Headache Drugs Product Table 105. AstraZeneca Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 106. AstraZeneca Recent Developments Table 107. Sun Pharma Company Details Table 108. Sun Pharma Business Overview Table 109. Sun Pharma Migraine Headache Drugs Product Table 110. Sun Pharma Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 111. Sun Pharma Recent Developments Table 112. Grunenthal Company Details Table 113. Grunenthal Business Overview Table 114. Grunenthal Migraine Headache Drugs Product Table 115. Grunenthal Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 116. Grunenthal Recent Developments Table 117. Endo Pharmaceuticals Company Details Table 118. Endo Pharmaceuticals Business Overview Table 119. Endo Pharmaceuticals Migraine Headache Drugs Product Table 120. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 121. Endo Pharmaceuticals Recent Developments Table 122. Mylan Company Details Table 123. Mylan Business Overview Table 124. Mylan Migraine Headache Drugs Product Table 125. Mylan Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 126. Mylan Recent Developments Table 127. Bayer Company Details Table 128. Bayer Business Overview Table 129. Bayer Migraine Headache Drugs Product Table 130. Bayer Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 131. Bayer Recent Developments Table 132. Amneal Pharmaceuticals Company Details Table 133. Amneal Pharmaceuticals Business Overview Table 134. Amneal Pharmaceuticals Migraine Headache Drugs Product Table 135. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 136. Amneal Pharmaceuticals Recent Developments Table 137. Apotex Company Details Table 138. Apotex Business Overview Table 139. Apotex Migraine Headache Drugs Product Table 140. Apotex Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 141. Apotex Recent Developments Table 142. Ajanta Pharma Company Details Table 143. Ajanta Pharma Business Overview Table 144. Ajanta Pharma Migraine Headache Drugs Product Table 145. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 146. Ajanta Pharma Recent Developments Table 147. Allergan Company Details Table 148. Allergan Business Overview Table 149. Allergan Migraine Headache Drugs Product Table 150. Allergan Revenue in Migraine Headache Drugs Business (2017-2022) & (US$ Million) Table 151. Allergan Recent Developments Table 152. Research Programs/Design for This Report Table 153. Key Data Information from Secondary Sources Table 154. Key Data Information from Primary Sources List of Figures Figure 1. Global Migraine Headache Drugs Market Share by Type: 2021 VS 2028 Figure 2. Almotriptan Features Figure 3. Eletriptan Features Figure 4. Sumatriptan Features Figure 5. Rizatriptan Features Figure 6. Zolmitriptan Features Figure 7. Naratriptan Features Figure 8. Frovatriptan Features Figure 9. Others Features Figure 10. Global Migraine Headache Drugs Market Share by Application: 2021 VS 2028 Figure 11. Acute Migraine Case Studies Figure 12. Common Migraine Case Studies Figure 13. Classic Migraine Case Studies Figure 14. Chronic Migraine Case Studies Figure 15. Other Migraines Case Studies Figure 16. Migraine Headache Drugs Report Years Considered Figure 17. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 18. Global Migraine Headache Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 19. Global Migraine Headache Drugs Market Share by Region: 2021 VS 2028 Figure 20. Global Migraine Headache Drugs Market Share by Players in 2021 Figure 21. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2021) Figure 22. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2021 Figure 23. North America Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 24. North America Migraine Headache Drugs Market Size Market Share by Type (2017-2028) Figure 25. North America Migraine Headache Drugs Market Size Market Share by Application (2017-2028) Figure 26. North America Migraine Headache Drugs Market Size Share by Country (2017-2028) Figure 27. United States Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Canada Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Europe Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 30. Europe Migraine Headache Drugs Market Size Market Share by Type (2017-2028) Figure 31. Europe Migraine Headache Drugs Market Size Market Share by Application (2017-2028) Figure 32. Europe Migraine Headache Drugs Market Size Share by Country (2017-2028) Figure 33. Germany Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. France Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. U.K. Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Italy Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Russia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Nordic Countries Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Asia-Pacific Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 40. Asia Pacific Migraine Headache Drugs Market Size Market Share by Type (2017-2028) Figure 41. Asia Pacific Migraine Headache Drugs Market Size Market Share by Application (2017-2028) Figure 42. Asia Pacific Migraine Headache Drugs Market Size Share by Region (2017-2028) Figure 43. China Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Japan Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. South Korea Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. India Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Australia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 49. Latin America Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 50. Latin America Migraine Headache Drugs Market Size Market Share by Type (2017-2028) Figure 51. Latin America Migraine Headache Drugs Market Size Market Share by Application (2017-2028) Figure 52. Latin America Migraine Headache Drugs Market Size Share by Country (2017-2028) Figure 53. Mexico Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Brazil Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Middle East & Africa Migraine Headache Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 56. Middle East and Africa Migraine Headache Drugs Market Size Market Share by Type (2017-2028) Figure 57. Middle East and Africa Migraine Headache Drugs Market Size Market Share by Application (2017-2028) Figure 58. Middle East and Africa Migraine Headache Drugs Market Size Share by Country (2017-2028) Figure 59. Turkey Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 60. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 61. UAE Migraine Headache Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 62. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 63. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 64. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 65. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 66. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 67. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 68. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 69. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 70. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 71. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 72. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 73. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 74. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 75. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 76. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 77. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 78. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2017-2022) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global UAV Propulsion System Market to Grow at a (CAGR) of 11.8% during the Forecast Period 2022-2030

26-Sep-2022 | Semiconductor

As specified in the market business insights exclusive report, the global UAV Propulsion System Market is projected to reach USD 34,258.31 million by 2030. Growth Drivers: Market dynamics are the forces that influence the prices and b ...

Global Autonomous Vehicle Simulation Solution Market to Grow at a (CAGR) of 12.8% during the Forecast Period 2022-2030

24-Sep-2022 | Automobile

As specified in our exclusive report, the global Autonomous Vehicle Simulation Solution Market is projected to reach USD 2,515 Million by 2030. Growth Drivers: Increasing adoption of connected ve ...

Global Active Space Debris Removal Market to Grow at a (CAGR) of 23.9% during the Forecast Period 2022-2030

23-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global  Active Space Debris Removal Market size is projected to reach USD 452.65 million by 2030. According to the European Space Agency (ESA), there have been more than 5,000 launches into space ...

Global Small Arms Market to Grow at a (CAGR) of 4.8% during the Forecast Period 2022-2030

22-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global Small Arms Market is projected to reach USD 12.88 billion by 2030. The defense sector is upgrading weapons and ammunition and adopting more modern weapon systems, and deployments at military bases, i ...

Global RFID in Healthcare Market to Grow at a (CAGR) of 21.5% during the Forecast Period 2022-2030

21-Sep-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global RFID in Healthcare Market is projected to reach USD 12.06 billion by 2030. How RFID is Use in Healthcare Market? RFID applications in healthcare have been positi ...

More News...